Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Axerion Therapeutics logo — Pioneering breakthrough therapies for Alzheimer's and spinal...

Axerion Therapeutics

Pioneering breakthrough therapies for Alzheimer's and spinal cord injuries through advanced neurological research.

Founded 2009 1 employees Venture round Total: $1.15M Biotechnology, Health Care

General Information

Company Name Axerion Therapeutics
Founded Year 2009
Employees 1
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Axerion Therapeutics. To contact Axerion Therapeutics, visit axeriontherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Axerion Therapeutics compare?

A PDF of Axerion Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Axerion Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Axerion Therapeutics

Axerion Therapeutics is a private biotechnology company founded in 2009, with a focus on developing innovative treatments for neurological diseases and injuries. The company's slogan "Pioneering breakthrough therapies for Alzheimer's and spinal cord injuries through advanced neurological research" reflects its dedication to addressing substantial unmet medical needs. Axerion's specialized technology platforms include inhibitors of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on neuron surfaces for Alzheimer’s disease, and a Nogo Receptor decoy protein designed to aid recovery of neurological function in spinal cord injuries and other conditions. The company has received a $400.00K Venture Round investment on 13 October 2011 from Connecticut Innovations, and is based in Connecticut. Axerion Therapeutics is at the forefront of pioneering treatments in the biotechnology and health care industries, leveraging research developed at Yale University to drive its advancements in the field.

Business keywords: neurological research, Alzheimer's disease, spinal cord injury, therapeutic treatments, intellectual property, Yale University, neurological function recovery, proprietary technology, neurological conditions, biotech startup, neurological therapies, Dr. Stephen Strittmatter, innovative treatments, unmet medical needs

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $400.00K 1
Connecticut Innovations
Connecticut Innovations
13 Oct 2011
Seed Round $750.00K 1
Connecticut Innovations
Connecticut Innovations
05 Apr 2010

Axerion Therapeutics Alternatives & Competitors

View All Alternatives
Axerion Therapeutics vs
BioAxone Therapeutic, Inc.
BioAxone Therapeutic, Inc.

Pioneering neuroscience solutions with breakthrough therapies for neurological disorders, including...

Series B
2 employees
Biotechnology, Health Care
Axerion Therapeutics vs
Cadence Biomedical
Cadence Biomedical

Cadence Biomedical, a commercial-stage medical device company headquartered in Seattle, Washington,...

Series B
4 employees
Biotechnology, Health Care
Axerion Therapeutics vs
Novoron Bioscience
Novoron Bioscience United States

Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spi...

Seed
17 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Axerion Therapeutics

Pioneering breakthrough therapies for Alzheimer's and spinal cord injuries through advanced neurological research.
Axerion Therapeutics was founded in 2009.
Axerion Therapeutics operates in Biotechnology and Health Care. Its work centres on neurological research, Alzheimer's disease, spinal cord injury and therapeutic treatments.
Axerion Therapeutics has approximately 1 employees.
Axerion Therapeutics has completed 2 funding rounds, raising a total of $1.15M. The latest funding stage is Venture round.
Top alternatives and competitors to Axerion Therapeutics include BioAxone Therapeutic, Inc., Cadence Biomedical, Novoron Bioscience, Visterra Inc., Neuralstem, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Axerion Therapeutics and BioAxone Therapeutic, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Axerion Therapeutics, https://bouncewatch.com/company/axerion-therapeutics, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout